Cell Therapy Bioprocessing

Cell Therapy Bioprocessing activity mainly focuses to accelerate the safe, cost- effective translations and clinical efficacious of cell therapies into commercial products. This activity covers the entire range of cell therapy activities as well as tissue engineering. In order to succeed, commercial success of at least a few late-stage products are required to develop which will be funded to develop next generation tools and technologies for this field. Recent achievements include, preclinical filing for Phase 1 clinical trials for cell therapy in acute spinal cord injury, clinical proof of concept studies in tissue- engineered trachea, clinical trials for tissue-engineered larynx and routine clinical practice in the regeneration of corneas. The future research priorities will focus on novel cell and bioprocess engineering techniques in order to improve the manufacturing efficacy and methods for health technology assessment to support rapid clinical adoption of new cell therapies.  

  • Upstream process and downstream process development for gene therapies
  • Technologies & Methodologies for Analytical Development
  • Manufacturing strategies for cell therapy products
  • Therapeutic area clinical update for cell therapy products
  • Opportunities and challenges for cell therapy commercialization
  • Regulatory challenges for the clinical manufacture of cell & gene therapy medicinal products

Related Conference of Cell Therapy Bioprocessing

Cell Therapy Bioprocessing Conference Speakers